Insulin‐dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia
- 14 September 2018
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (1) , e27437
Abstract
Pancreatitis is a frequent toxicity to acute lymphoblastic leukemia (ALL) treatment, significantly associated with asparaginase use, and may be followed by severe complications such as acute hyperglycaemia, need for mechanical ventilation, pseudocysts, and death. Here, we provide novel data on seven patients diagnosed with diabetes after pancreatitis and still requiring insulin treatment after a median follow‐up of 4.2 years (range: 1.7–9.2). We describe the clinical course of pancreatitis and illustrate the association between pancreatic pseudocysts, older age, and development of insulin‐dependent diabetes. Together, this study documents the persisting burden of pancreatitis in childhood ALL and underlines the need for plasma glucose level monitoring.Keywords
Funding Information
- Børnecancerfonden
This publication has 6 references indexed in Scilit:
- Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyThe Lancet Oncology, 2017
- Management of pancreatogenic diabetes: challenges and solutionsDiabetes, Metabolic Syndrome and Obesity, 2016
- Beta Cell Transplantation and Regeneration2016
- Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysisGut, 2013
- Acute Pancreatitis in Children With Acute Lymphoblastic Leukemia Treated With L-AsparaginaseJournal of Pediatric Hematology/Oncology, 2009
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2009